Skip to main content
Premium Trial:

Request an Annual Quote

Age Labs Gets €1M From Research Council of Norway

NEW YORK (GenomeWeb) – Age Labs, an Oslo-based biomarker discovery company, has been awarded €1 million (about $1.1 million) in R&D funding from the Research Council of Norway to support the development of a unique biomarker for aging.

Specifically, the company is developing a methylated DNA biomarker that will predict all-cause mortality risk and risk of developing certain age-related diseases. The company expects the biomarker to enable pharmaceutical companies to increase the probability of success in clinical trials by providing more accurate risk information about patients participating in the trials.

Age Labs is leading the four-year project, which includes collaborators AbbVie, Fürst Medical Laboratory, the Norwegian Institute of Public Health, and Oslo University.

According to its website, Age Labs applies machine learning techniques on large epigenetic datasets from Norwegian and international biobanks.

The Scan

For STEM Students to Stay

New policy changes will make it easier for international STEM students to stay in the US after graduation, the Wall Street Journal reports.

To Inform or Not, To Know or Not

The New York Times writes that some genetic biobanks may re-contact donors if they spot something troublesome, but it notes that not all donors want that information.

Rapid Test Studies

Researchers are examining why rapid tests may be less effective at detecting the Omicron variant and how to improve them, NPR says.

PLOS Papers on SARS-CoV-2 Diversity in Delaware, Metastatic Breast Cancer, Adiposity GWAS

In PLOS this week: genomic analysis of SARS-CoV-2 isolates from Delaware, gene expression and protein-protein interaction patterns in metastatic breast cancer, and more.